Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT07066722 · ClinicalTrials.gov registry record · Phase 1

A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults

A Phase 1 study of HIV Infections, sponsored by ViiV Healthcare.

Completed
Registry status
Phase 1
Development phase
126
Enrollment target
2
Study locations

NCT07066722 is a Phase 1 study of HIV Infections that has completed, run by ViiV Healthcare. The registered enrollment target is 126 participants, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (72% lower). The trial reports 2 study locations across 2 states.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT07066722, a Phase 1 study of HIV Infections, has completed, sponsored by ViiV Healthcare.

COMPLETED
Registry status
Phase 1
Development phase
126 participants
Enrollment target
2
Study locations

Study Summary

The aim of the study is to gather information on how the drug behaves in healthy adults, how it is absorbed, and how it interacts when taken with other medicines.

Conditions Studied

Interventions

  • DRUG Metformin
  • DRUG Itraconazole
  • DRUG VH4524184
  • DRUG Rifabutin
  • DRUG Phenytoin

Study Locations (2)

Kansas

  • GSK Investigational Site - Lenexa

Utah

  • GSK Investigational Site - Salt Lake City

Trial Details

FieldValue
Enrollment Target 126 participants
Start Date 2025-07-07
Est. Completion 2025-12-17
Phase Phase 1

Sponsor

ViiV Healthcare

182 total trials

What the Registry Record Tells You About NCT07066722

The ClinicalTrials.gov registry entry for NCT07066722 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 126 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 446-participant average among 542 other HIV Infections trials with a reported enrollment target (72% lower). The listed sponsor is ViiV Healthcare, which has 182 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with HIV Infections appearing as the primary indexed condition, and to 5 interventions - of which Metformin is the first listed.

NCT07066722 reports 2 study locations spanning 2 distinct geographic areas - top geographies include Kansas, Utah.

Frequently Asked Questions

What is clinical trial NCT07066722 about?

NCT07066722 is a clinical study titled "A Study to Evaluate VH4524184 Tablet Absorption, Effects of Food, and Interactions With Other Drugs in Healthy Adults". The aim of the study is to gather information on how the drug behaves in healthy adults, how it is absorbed, and how it interacts when taken with other medicines.

What is the current status of trial NCT07066722?

This trial is currently completed. It is a Phase 1 study. The enrollment target is 126 participants. The study started on 2025-07-07. Estimated completion is 2025-12-17.

What conditions does trial NCT07066722 study?

This clinical trial studies the following conditions: HIV Infections.

What interventions are being tested in trial NCT07066722?

The interventions under investigation include: Metformin (DRUG), Itraconazole (DRUG), VH4524184 (DRUG), Rifabutin (DRUG), Phenytoin (DRUG).

Who is sponsoring clinical trial NCT07066722?

This trial is sponsored by ViiV Healthcare, which has 182 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT07066722 being conducted?

This trial has 2 study locations across Kansas, Utah. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for HIV Infections

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.